Emerging Roles of Fibroblast Growth Factor 10 in Cancer

Emerging Roles of Fibroblast Growth Factor 10 in Cancer

Whilst cross-talk between stroma and epithelium is critical for tissue development and homeostasis, aberrant paracrine stimulation can result in neoplastic transformation. Chronic stimulation of epithelial cells with paracrine Fibroblast Growth Factor 10 (FGF10) has been implicated in multiple cance...

Full description

Bibliographic Details
Main Authors:	Natasha S. Clayton, Richard P. Grose
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-10-01
Series:	Frontiers in Genetics
Subjects:	FGF10 FGFR2 FGFR2b FGFR1 FGFR1b cancer
Online Access:	https://www.frontiersin.org/article/10.3389/fgene.2018.00499/full

Similar Items

Biological Significance and Targeting of the FGFR Axis in Cancer
by: Athina-Myrto Chioni, et al.
Published: (2021-11-01)

FGFR1–4 RNA-Based Gene Alteration and Expression Analysis in Squamous Non-Small Cell Lung Cancer
by: Joanna Moes-Sosnowska, et al.
Published: (2022-09-01)

Evidence for Overlapping and Distinct Biological Activities and Transcriptional Targets Triggered by Fibroblast Growth Factor Receptor 2b Signaling between Mid- and Early Pseudoglandular Stages of Mouse Lung Development
by: Matthew R. Jones, et al.
Published: (2020-05-01)

Integrated Analysis of Structural Variation and RNA Expression of FGFR2 and Its Splicing Modulator ESRP1 Highlight the <i>ESRP1</i><sup>amp</sup>-<i>FGFR2</i><sup>norm</sup>-<i>FGFR2-IIIc</i><sup>high</sup> Axis in Diffuse Gastric Cancer
by: Sara Pinto Teles, et al.
Published: (2019-12-01)

Preclinical characterization of CPL304110 as a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3 for gastric, bladder, and squamous cell lung cancer
by: Delfina Popiel, et al.
Published: (2024-01-01)

Expression Profile of Fibroblast Growth Factor Receptors, Keratinocyte Differentiation Markers, and Epithelial Mesenchymal Transition-Related Genes in Actinic Keratosis: A Possible Predictive Factor for Malignant Progression?
by: Flavia Persechino, et al.
Published: (2021-04-01)

Developmental impairments of craniofacial bone and cartilage in transgenic mice expressing FGF10
by: Hirotaka Yoshioka, et al.
Published: (2023-06-01)

Differential expression of FGFRs signaling pathway components in bladder cancer: A step toward personalized medicine
by: Ousati Ashtiani Z, et al.
Published: (2017-12-01)

Disruption of the suprachiasmatic nucleus in fibroblast growth factor signaling-deficient mice
by: Ann Virginia Miller, et al.
Published: (2016-02-01)

Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma
by: Vivian Chua, et al.
Published: (2019-02-01)

Fibroblast Growth Factor Receptor 2 Isoforms Detected via Novel RNA ISH as Predictive Biomarkers for Progestin Therapy in Atypical Hyperplasia and Low-Grade Endometrial Cancer
by: Asmerom T. Sengal, et al.
Published: (2021-04-01)

Chronic Trazodone and Citalopram Treatments Increase Trophic Factor and Circadian Rhythm Gene Expression in Rat Brain Regions Relevant for Antidepressant Efficacy
by: Lucia Carboni, et al.
Published: (2022-11-01)

FGF/FGFR Signaling in Hepatocellular Carcinoma: From Carcinogenesis to Recent Therapeutic Intervention
by: Yijun Wang, et al.
Published: (2021-03-01)

Fibroblast Growth Factor Receptor Inhibitors Decrease Proliferation of Melanoma Cell Lines and Their Activity Is Modulated by Vitamin D
by: Anna Piotrowska, et al.
Published: (2024-02-01)

FGF21 prevents neuronal cell ferroptosis after spinal cord injury by activating the FGFR1/β-Klotho pathway
by: Tianli Xu, et al.
Published: (2023-10-01)

FRS2-independent GRB2 interaction with FGFR2 is not required for embryonic development
by: James F. Clark, et al.
Published: (2023-07-01)

Hepatocyte survival and proliferation by fibroblast growth factor 7 attenuates liver inflammation, and fibrogenesis during acute liver injury via paracrine mechanisms
by: Eline Geervliet, et al.
Published: (2023-11-01)

Immunohistochemical Expression Pattern of FGFR1, FGFR2, RIP5, and HIP2 in Developing and Postnatal Kidneys of <i>Dab1<sup>−/−</sup></i> (<i>yotari</i>) Mice
by: Nela Kelam, et al.
Published: (2022-02-01)

A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis
by: Yanran Bi, et al.
Published: (2024-01-01)

Efficacy and Selectivity of FGF2-Saporin Cytosolically Delivered by PCI in Cells Overexpressing FGFR1
by: Aurora K. Vikan, et al.
Published: (2021-06-01)

FGF1 Fusions with the Fc Fragment of IgG1 for the Assembly of GFPpolygons-Mediated Multivalent Complexes Recognizing FGFRs
by: Marta Poźniak, et al.
Published: (2021-07-01)

Dual activating FGFR1 mutations in pediatric pilomyxoid astrocytoma
by: Elena I. Fomchenko, et al.
Published: (2021-02-01)

Recombinant expression in E. coli of human FGFR2 with its transmembrane and extracellular domains
by: Adam Bajinting, et al.
Published: (2017-06-01)

Paradoxical cancer cell proliferation after FGFR inhibition through decreased p21 signaling in FGFR1-amplified breast cancer cells
by: Feng Chi, et al.
Published: (2024-03-01)

Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma
by: Jerry T. Wu, et al.
Published: (2023-08-01)

Genetic variants of FGFR family associated with height, hypertension, and osteoporosis
by: Hye-Won Cho, et al.
Published: (2023-01-01)

Association between Circulating Fibroblast Growth Factor 21 and Aggressiveness in Thyroid Cancer
by: Yea Eun Kang, et al.
Published: (2019-08-01)

Fibrosis-Associated Signaling Molecules Are Differentially Expressed in Palmar Connective Tissues of Patients with Carpal Tunnel Syndrome and Dupuytren’s Disease
by: Ivo Tripković, et al.
Published: (2022-12-01)

Síndrome de Apert, una aproximación para un diagnóstico clínico. Reporte de caso
by: Diana Ramírez, et al.
Published: (2010-01-01)

MicroRNA-Regulated Rickettsial Invasion into Host Endothelium via Fibroblast Growth Factor 2 and Its Receptor FGFR1
by: Abha Sahni, et al.
Published: (2018-12-01)

Fibroblast Growth Factor Receptor 4 Targeting in Cancer: New Insights into Mechanisms and Therapeutic Strategies
by: Liwei Lang, et al.
Published: (2019-01-01)

FGFR2c Upregulation Contributes to Cancer-Associated Fibroblast Program Activation and to Enhanced Autophagy in Actinic Keratosis-Derived Dermal Fibroblasts: A Possible Role in Precancerous Cell/Stromal Cell Crosstalk
by: Luisa Guttieri, et al.
Published: (2023-03-01)

Short‐term semaglutide treatment improves FGF21 responsiveness in primary hepatocytes isolated from high fat diet challenged mice
by: Jia Nuo Feng, et al.
Published: (2023-03-01)

ADAMDEC1 and FGF2/FGFR1 signaling constitute a positive feedback loop to maintain GBM cancer stem cells
by: Ana Jimenez-Pascual, et al.
Published: (2020-01-01)

Cancer-associated fibroblast-secreted FGF7 as an ovarian cancer progression promoter
by: Songwei Feng, et al.
Published: (2024-03-01)

The Role of Fibroblast Growth Factor (FGF) Signaling in Tissue Repair and Regeneration
by: Mariya Farooq, et al.
Published: (2021-11-01)

FGF8–FGFR1 signaling regulates human GnRH neuron differentiation in a time- and dose-dependent manner
by: Venkatram Yellapragada, et al.
Published: (2022-08-01)

The FGF/FGFR system in the microglial neuroinflammation with Borrelia burgdorferi: likely intersectionality with other neurological conditions
by: Geetha Parthasarathy, et al.
Published: (2023-01-01)

FGFR4 Inhibitor BLU9931 Attenuates Pancreatic Cancer Cell Proliferation and Invasion While Inducing Senescence: Evidence for Senolytic Therapy Potential in Pancreatic Cancer
by: Norihiko Sasaki, et al.
Published: (2020-10-01)

Overexpression of Fgfr2c causes craniofacial bone hypoplasia and ameliorates craniosynostosis in the Crouzon mouse
by: Kevin K. L. Lee, et al.
Published: (2018-11-01)